Related Experiment Video
Updated: Dec 27, 2025

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents
Published on: August 22, 2025
Mu-opioid antagonism in the treatment of cannabis use disorder
Oussama Kebir1, Xavier Laqueille1, Fayçal Mouaffak1
1From the Service d’Addictologie Moreau de Tours, Centre hospitalier Sainte Anne, GHU Paris Psychiatrie & Neurosciences, Paris, France (Kebir, Laqueille); the Laboratoire physiopathologie des maladies psychiatriques, Institut de Psychiatrie et Neurosciences de Paris, INSERM U1266, Paris, France (Kebir); and the Unité de Psychiatrie de Liaison, d’Urgence et de Recherche, Pôle 93G04, EPS Ville Evrard, Saint Denis, France (Mouaffak).
No abstract available in PubMed .
Related Concept Videos
Analgesia and Pain Management
Opioid Receptors: Overview
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Opioid Analgesics: Morphine and Other Natural Cogeners
Drug-Receptor Interaction: Antagonist
Antagonists can be classified as competitive or noncompetitive based on their...

